Selective inhibition of HDAC8 ameliorates arginine metabolism disorders, alleviates intestinal injury in NEC mouse model, and attenuates the production of pro-inflammatory factors IL6, IL-1β, and TNF-α (32). The gene discussed is HDAC8; the disease is necrotizing enterocolitis.